Pneumococcal vaccine

16 Jan 2014

During the European Respiratory Society (ERS) annual international conference in Barcelona, 8.9.13,  Symposium on “New understanding of pneumococcal vaccination” provided recent information that adult mortality from Streptococcus Pneumococcus (SP) is still 20%. Since the introduction of “PCV13” (pneumococcal vaccine, 13 valent) in the UK in April 2010, there is an increased colonisation rate in day care centers, nurseries and creshes up to 50% and mortality is decreasing. In the developing world, among childen 5 years of age. 1 million death/year is occurring with SP